Bottom line
How much do XLV and FTXH overlap?
50% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 55.2% of XLV's assets and 54.2% of FTXH's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings XLV and FTXH have in common
| Holding | % of XLV | % of FTXH | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 16.51% | 7.77% | 7.77% |
| Johnson & Johnson | 10.64% | 6.96% | 6.96% |
| AbbVie Inc | 7.74% | 7.39% | 7.39% |
| Merck & Co Inc | 5.52% | 7.07% | 5.52% |
| Amgen Inc | 3.40% | 3.18% | 3.18% |
| Gilead Sciences Inc | 2.73% | 2.89% | 2.73% |
| Pfizer Inc | 2.39% | 2.97% | 2.39% |
| Vertex Pharmaceuticals Inc | 2.19% | 3.41% | 2.19% |
| Bristol-Myers Squibb Co | 2.05% | 6.29% | 2.05% |
| Regeneron Pharmaceuticals Inc | 1.08% | 2.72% | 1.08% |
| Cardinal Health Inc | 0.97% | 3.53% | 0.97% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in XLV
- UnitedHealth Group Inc — 6.57%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Intuitive Surgical Inc — 2.45%
- CVS Health Corp — 2.30%
- Danaher Corp — 2.09%
- Stryker Corp — 1.89%
- Medtronic PLC — 1.75%
- McKesson Corp — 1.58%
- Elevance Health Inc — 1.46%
- Cigna Group/The — 1.27%
- Boston Scientific Corp — 1.10%
- HCA Healthcare Inc — 1.05%
- Cencora Inc — 0.96%
Only in FTXH
- Biogen Inc — 3.84%
- Viatris Inc — 3.62%
- United Therapeutics Corp — 2.72%
- Jazz Pharmaceuticals Plc — 2.49%
- Incyte Corp — 2.39%
- Illumina Inc — 1.98%
- Zoetis Inc — 1.87%
- Exelixis Inc — 1.72%
- Charles River Laboratories International Inc — 1.49%
- Medpace Holdings Inc — 1.41%
- Ptc Therapeutics Inc — 1.37%
- Neurocrine Biosciences Inc — 1.37%
- Alkermes Plc — 1.35%
- Halozyme Therapeutics Inc — 1.21%
Asset mix
| Asset type | XLV | FTXH |
|---|---|---|
| Stocks | 99.7% | 99.9% |
| Cash & short-term funds | 0.3% | 0.1% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | XLV | FTXH |
|---|---|---|
| US | 97.9% | 95.6% |
| IE | 2.1% | 3.8% |
| BM | — | 0.6% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do XLV and FTXH overlap?
What stocks do XLV and FTXH have in common?
Should I own both XLV and FTXH?
Which holds more stocks, XLV or FTXH?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.